Upcoming Events
Search Result For "UGC".
- Event Type
- Event Category
- Event Country
- Event Date
Event Type
Categories
Country
City
Date
Toxicities continue to pose the most significant challenge in the progression of antibody-drug conjugates to the clinic, and with increasing compan...
With linker and conjugate deals dominating the ADC industry and more companies shifting their focus towards the chemistries behind linkers and conj...
With cutting-edge strategies and industry insights, the 2nd ADC Process Development Summit is back with a mission to boost conjugation yield, optim...
Join us at the inaugural Novel Targeting Moiety and Payload Conjugate Summit Europe, the premier event for Europe's burgeoning novel drug conjugate...
Antibody-drug conjugates (ADCs) have emerged as a rapidly evolving, highly promising class of oncology drugs, with 12 approvals and many more in de...
This course provides an update for clinicians on the assessment and treatment of addictive disorders with an emphasis on the newest information rel...
Welcome to the 4th ADC Target Selection Summit! Get the First Most Important Decision Right. The ADC field continues to grow, saturating the ind...
Welcome to the 4th Novel Conjugates Summit! We are witnessing a surging 83% growth of novel drug conjugates, with major collaborations between N...
Following Isen's groundbreaking $1B+ ADC deal with China-based Foreseen Biotechnology, the rapid rise of new companies, billions of dollars in inve...
The global demand for highly potent drugs is growing rapidly, with the market projected to reach $46.9B by 2030, driven by innovations in drug deli...
Uniting Biotech and Pharma Experts to Exchange Insights on Oligonucleotide Analytical Development and CMC.
Despite milest...
As ADC approvals grow and pipelines expand, dose selection has become one of the field’s biggest challenges, and Project Optimus has resul...
Loading More...
